References
- George S. L., Aur R.J.A., Mauer A. M., Simone J. V. A reappraisal of the results of stopping therapy in childhood leukemia. New Engl J Med 1979; 300: 269–273
- Gale R. P., Cline MJ, the U.C.L.A. Acute Leukemia Study Group: High remission induction rates in acute myelogenous leukemia. Lancet 1977; 1: 497–499
- Gale R. P. Advances in the treatment of acute myelogenous leukemia. New Engl J Med 1979; 300: 1189–1199
- Prolla J. C., Kirsner J. B. The gastrointestinal lesions and complications of the leukemias. Ann Intern Med 1964; 61: 1084–1103
- Wagner M. L., Rosenberg H. S., Fernbach D. J., Singleton E. B. Typhilitis: A complication of leukemia in childhood. Am J Roentgenol 1970; 109: 341–350
- Sherman N. J., Wooley M. M. The ileocecal syndrome in acute childhood leukemia. Arch Surg 1973; 107: 39–42
- Steinberg D., Gold J., Brodin A. Necrotizing enterocolitis in leukemia. Arch Intern Med 1973; 131: 538–544
- Kies M. S., Luedke D. W., Boyd J. F., McCue M. J. Neutropenic enterocolitis: Two case reports of long term survival following surgery. Cancer 1979; 43: 730–734
- Varki A. P., Armitage J. O., Feagler J. R. Typhilitis in acute leukemia: Successful treatment of early surgical intervention. Cancer 1979; 43: 695–697
- Pokorney B. H., Jones J. M., Shaikh B. S., Aber R. C. Typhilitis: A treatable cause of recurrent septicemia. J Med Assoc 1980; 243: 682–683
- Exelby P. R., Ghundchi A., Lansigan N., Schwartz I. Management of the acute abdomen in children with leukemia. Cancer 1975; 35: 826–829
- Seligman B. R., Rosner F., Ritz N. D. Major surgery in patients with acute leukemia. Am J Surg 1972; 124: 629–633
- Ecker J. A., Williams R. G., McKittrick J. E. Pseudomembranous enterocolitis: An unwelcome gastrointestinal complication of antibiotic therapy. Am J Gastroenterol 1970; 54: 214–228
- Salvin R. E., Dias MA., Saral R. Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols. Cancer 1978; 42: 1747–1759
- Leach W. B., Laster W. R., Mayo J. G., Griswold D. P., Schabel F. M. Toxicity studies in mice treated with 1-beta-D-ara-binofuranosylcytosine (ARA-C). Cancer Res 1969; 19: 529–535
- Lenaz L., Sternberg S. C., Philips F. S. Cytotoxic effects of 1-beta-D-arabinofuranosyl-5-fluorocytosine and of 1-beta-D-ara-binofuranosylcytosine in proliferating tissues in mice. Cancer Res 1969; 29: 1790–1798
- Paterson A.R.P., Jakobs E.W., Lanzon G. J., Weinstein W. M. Drug sequence dependent toxicity and small bowel mucosal injury in mice treated with low doses of 3-deazauridine and 1-beta-D-arabinofuranosylcytosine. Cancer Res 1979; 39: 2216–2219
- Momparler R. L. A model for the chemotherapy of acute leukemia with 1-beta-D-arabinofuranosylcytosine. Cancer Res 1974; 34: 1775–1787
- DeVita V. T., Serpick A. A., Carbone P. P. Combination chemotherapy in treatment of advanced Hodgkin's disease. Ann Intern Med 1970; 73: 881–895
- Kingry R. L., Hobson R. W., Muir R. W. Cecal necrosis and perforation with systemic chemotherapy. Am Surg 1973; 39: 129–133
- Matolo N. M., Garfinkle S. E., Wolfman E. F. Intestinal necrosis and perforation in patients receiving immunosuppressive drugs. Am J Surg 1976; 132: 753–754